Stock Rich List
#1495 on the rich list of 14,452 insiders

Matthew W. Foehr

Insider at Ligand Pharmaceuticals; President and CEO at OmniAb; Director at Viking Therapeutics. Based in Emeryville, California.

$100M
in disclosed stock, −$3.3M (−3.21%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
1495th of 14,452
Companies held
3
Largest holding
LGND, 74.4% of total
Latest SEC filing
Apr 7, 2026

What the $100M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Ligand Pharmaceuticals LGND
Common Stock
Directly259,986
split-adjusted
$286.94$74.6M74.4%Form 4, Nov 1, 2022
OmniAb OABI
Common Stock
Directly4,420,492$5.03$22.2M22.2%Form 4, Apr 7, 2026
Viking Therapeutics VKTX
Common Stock, par value $0.00001 per share
Directly135,186$25.84$3.5M3.5%Form 4, Jan 2, 2026

Share counts are the amounts Matthew W. Foehr reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Apr 7, 2026SoldOABI19,244$1.49$29KView
Feb 18, 2026SoldOABI30,843$1.71$53KView
Feb 17, 2026SoldOABI20,754$1.70$35KView
Jan 2, 2026SoldVKTX16,000$35.11$562KView
Dec 8, 2025SoldOABI13,666$1.96$27KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
1492Veronique Lecault
Chief Operating Officer, AbCellera Biologics
$101M−$5.3M (−4.99%)
1493David J. Rosa
Chief Executive Officer (CEO), Intuitive Surgical. Sunnyvale, CA
$101M−$3.4M (−3.26%)
1494Glenn Darrel Sanford
CEO and Chairman of the Board, AGNT. Bellingham, WA
$100M−$3.6M (−3.45%)
1495Matthew W. Foehr
Insider, Ligand Pharmaceuticals. Emeryville, CA
$100M−$3.3M (−3.21%)
1496Michael Gonnella
Chief Financial Officer, Pershing Square. New York, NY
$100M−$9.9M (−9.01%)
1497Anne E. White
EVP & Pres, Lilly Neuroscience, Eli Lilly and. Indianapolis, IN
$100M−$2.3M (−2.29%)
1498Gregory E. Johnson
Executive Chairman, Franklin Templeton. San Mateo, CA
$100M−$3.5M (−3.40%)

Other Ligand Pharmaceuticals insiders

All LGND insiders

Questions

How much stock does Matthew W. Foehr own?

Matthew W. Foehr holds $100,328,595 in listed stock based on SEC filings and current prices, mostly Ligand Pharmaceuticals (LGND). That ranks 1495th on the Stock Rich List.

Is this Matthew W. Foehr's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Matthew W. Foehr last buy or sell stock?

The most recent open-market trade on file is a sale of 19,244 OABI shares on Apr 7, 2026 at $1.49.